Literature DB >> 19597700

Diversity in arrestin function.

Ryan T Kendall1, Louis M Luttrell.   

Abstract

The termination of heptahelical receptor signaling is a multilevel process coordinated, in large part, by members of the arrestin family of proteins. Arrestin binding to agonist-occupied receptors promotes desensitization by interrupting receptor-G protein coupling, while simultaneously recruiting machinery for receptor endocytosis, vesicular trafficking, and receptor fate determination. By simultaneously binding other proteins, arrestins also act as ligand-regulated scaffolds that recruit protein and lipid kinase, phosphatase, phosphodiesterase, and ubiquitin ligase activity into receptor-based multiprotein 'signalsome' complexes. Arrestin-binding thus 'switches' receptors from a transient G protein-coupled state to a persistent arrestin-coupled state that continues to signal as the receptor transits intracellular compartments. While it is clear that signalsome assembly has profound effects on the duration and spatial characteristics of heptahelical receptor signals, the physiologic functions of this novel signaling mechanism are poorly understood. Growing evidence suggests that signalsomes regulate such diverse processes as endocytosis and exocytosis, cell migration, survival, and contractility.

Mesh:

Substances:

Year:  2009        PMID: 19597700     DOI: 10.1007/s00018-009-0088-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  161 in total

1.  Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

2.  c-Src-mediated phosphorylation of AP-2 reveals a general mechanism for receptors internalizing through the clathrin pathway.

Authors:  Brandon Zimmerman; May Simaan; Mi-Hye Lee; Louis M Luttrell; Stéphane A Laporte
Journal:  Cell Signal       Date:  2008-10-01       Impact factor: 4.315

3.  The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.

Authors:  K A DeFea; Z D Vaughn; E M O'Bryan; D Nishijima; O Déry; N W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

5.  beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation.

Authors:  D A Conner; M A Mathier; R M Mortensen; M Christe; S F Vatner; C E Seidman; J G Seidman
Journal:  Circ Res       Date:  1997-12       Impact factor: 17.367

6.  Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors.

Authors:  T J Gardella; M D Luck; G S Jensen; E Schipani; J T Potts; H Jüppner
Journal:  Endocrinology       Date:  1996-09       Impact factor: 4.736

7.  beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.

Authors:  Diane Gesty-Palmer; Hesham El Shewy; Trudy A Kohout; Louis M Luttrell
Journal:  J Biol Chem       Date:  2005-07-15       Impact factor: 5.157

8.  Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2005-02-07       Impact factor: 5.157

9.  Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2003-02-06       Impact factor: 5.157

10.  Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.

Authors:  Mounia Azzi; Pascale G Charest; Stéphane Angers; Guy Rousseau; Trudy Kohout; Michel Bouvier; Graciela Piñeyro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

View more
  27 in total

1.  Influence of the accessory protein SET on M3 muscarinic receptor phosphorylation and G protein coupling.

Authors:  Violaine Simon; Sukru S Oner; Joelle Cohen-Tannoudji; Andrew B Tobin; Stephen M Lanier
Journal:  Mol Pharmacol       Date:  2012-03-30       Impact factor: 4.436

Review 2.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

3.  Characterization of the expression pattern of adrenergic receptors in rat taste buds.

Authors:  Y Zhang; T Kolli; R Hivley; L Jaber; F I Zhao; J Yan; S Herness
Journal:  Neuroscience       Date:  2010-05-15       Impact factor: 3.590

4.  β(2)-Adrenoceptors increase translocation of GLUT4 via GPCR kinase sites in the receptor C-terminal tail.

Authors:  Nodi Dehvari; Dana S Hutchinson; Julia Nevzorova; Olof S Dallner; Masaaki Sato; Martina Kocan; Jon Merlin; Bronwyn A Evans; Roger J Summers; Tore Bengtsson
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

5.  Chronic loss of noradrenergic tone produces β-arrestin2-mediated cocaine hypersensitivity and alters cellular D2 responses in the nucleus accumbens.

Authors:  Meriem Gaval-Cruz; Richard B Goertz; Daniel J Puttick; Dawn E Bowles; Rebecca C Meyer; Randy A Hall; Daijin Ko; Carlos A Paladini; David Weinshenker
Journal:  Addict Biol       Date:  2014-08-13       Impact factor: 4.280

6.  Studying ligand efficacy at G protein-coupled receptors using FRET.

Authors:  Jean-Pierre Vilardaga
Journal:  Methods Mol Biol       Date:  2011

7.  ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4.

Authors:  K M Draheim; H-B Chen; Q Tao; N Moore; M Roche; S Lyle
Journal:  Oncogene       Date:  2010-07-05       Impact factor: 9.867

8.  Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.

Authors:  Marie Mi Bonde; Jonas Tind Hansen; Samra Joke Sanni; Stig Haunsø; Steen Gammeltoft; Christina Lyngsø; Jakob Lerche Hansen
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  β-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1/β-catenin signaling in mice.

Authors:  Huiyan Xu; Quanxin Li; Jiang Liu; Jiaqing Zhu; Liang Li; Ziying Wang; Yan Zhang; Yu Sun; Jinpeng Sun; Rong Wang; Fan Yi
Journal:  J Mol Med (Berl)       Date:  2017-11-07       Impact factor: 4.599

10.  A high-content, live-cell, and real-time approach to the quantitation of ligand-induced β-Arrestin2 and Class A/Class B GPCR mobilization.

Authors:  Anthony P Leonard; Kathryn M Appleton; Louis M Luttrell; Yuri K Peterson
Journal:  Microsc Microanal       Date:  2013-01-28       Impact factor: 4.127

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.